Review: taking Sumatriptan succinate and Buspirone hydrochloride together


Summary

Drug interactions are reported among people who take Sumatriptan succinate and Buspirone hydrochloride together. This review analyzes the effectiveness and drug interactions between Sumatriptan succinate and Buspirone hydrochloride. It is created by eHealthMe based on reports of 244 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Sumatriptan succinate and Buspirone hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Sumatriptan Succinate

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. (latest outcomes from Sumatriptan succinate 2,684 users)

Buspirone Hydrochloride

Buspirone hydrochloride has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. (latest outcomes from Buspirone hydrochloride 1,054 users)

On Aug, 28, 2016

244 people who take Sumatriptan Succinate, Buspirone Hydrochloride are studied.


Number of reports submitted per year:

Sumatriptan succinate and Buspirone hydrochloride drug interactions.

Drug effectiveness over time:

Sumatriptan Succinate:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Buspirone Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Sumatriptan Succinate:
  • female: 42.0% - (3 of 7 people)
  • male: 0.0% - (0 of 0 people)
Buspirone Hydrochloride:
  • female: 14.0% - (1 of 7 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Sumatriptan Succinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Buspirone Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • vomiting
  • abdominal discomfort
  • abdominal pain upper
  • back pain
  • biliary dyskinesia
  • gallbladder injury
  • nausea
  • borderline personality disorder
  • contusion
  • diarrhoea
6 - 12 months:
  • facial pain
  • low blood pressure
  • muscle spasms
  • neck pain
1 - 2 years:
  • hippus
2 - 5 years:
  • acid reflux
  • anxiety
  • chronic depression
  • cholecystitis chronic
  • gallbladder disorder
  • pain
  • pancreatitis
  • sphincter of oddi dysfunction
  • deep vein thrombosis
  • hippus
5 - 10 years:
  • abnormal behaviour
  • anxiety
  • borderline personality disorder
  • breast cancer female
  • depression
  • irritability
  • suicide attempt
10+ years:
  • anxiety
  • acid reflux
  • chronic depression
  • aggression
  • decubitus ulcer
  • depression
  • intentional overdose
  • liver function test abnormal
  • pancreatitis
  • renal failure
not specified:
  • drug ineffective
  • dyspnoea
  • headache
  • anxiety
  • fatigue
  • dizziness
  • chest pain
  • suicidal ideation
  • depression
  • sleep apnoea syndrome

Most common drug interactions by gender *:

female:
  • drug ineffective
  • nausea
  • confusional state
  • abdominal pain upper
  • back pain
  • suicidal ideation
  • dyspnoea
  • anxiety
  • headache
  • asthenia
male:
  • fatigue
  • anxiety
  • myocardial infarction
  • blood cholesterol increased
  • chest pain
  • depression
  • headache
  • asthma
  • dizziness
  • dry skin

Most common drug interactions by age *:

10-19:
  • abdominal discomfort
  • abdominal pain upper
  • back pain
  • biliary dyskinesia
  • gallbladder injury
  • nausea
  • vomiting
  • pain
  • cholecystitis chronic
  • gallbladder disorder
20-29:
  • dyspnoea
  • dizziness
  • headache
  • sleep apnoea syndrome
  • palpitations
  • asthma
  • chest pain
  • panic attack
  • abdominal pain
  • anxiety
30-39:
  • completed suicide
  • acid reflux
  • anxiety
  • chronic depression
  • coma
  • diabetes mellitus
  • intentional overdose
  • activities of daily living impaired
  • amnesia
  • blood cholesterol increased
40-49:
  • anxiety
  • drug ineffective
  • nausea
  • abdominal distension
  • constipation
  • colitis ischaemic
  • dyspnoea
  • pain
  • asthenia
  • blood in stool
50-59:
  • depression
  • aggression
  • anger
  • anxiety
  • arthralgia
  • drug ineffective
  • headache
  • hypomania
  • fatigue
  • bipolar disorder
60+:
  • gait disturbance
  • anaemia
  • migraine
  • deafness unilateral
  • facial paresis
  • disturbance in attention
  • emotional disorder
  • hypertension
  • insomnia
  • oropharyngeal pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Sumatriptan succinate and Buspirone hydrochloride?

Can you answer these questions?

More questions for: Sumatriptan succinate, Buspirone hydrochloride

You may be interested in these reviews

More reviews for: Sumatriptan succinate, Buspirone hydrochloride

On eHealthMe, Sumatriptan succinate (sumatriptan succinate) is often used to treat migraine. Buspirone hydrochloride (buspirone hydrochloride) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.